Compass Therapeutics, Inc. (CMPX) › Shareholders' EquityCompass Therapeutics, Inc. (CMPX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$84.77M2019: $11.27M2020: $39.95M2021: $140.08M2022: $181.64M2023: $148.54M2024: $125.23M2025: $196.79M$196.79M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$196.79M+57.1%2024$125.23M-15.7%2023$148.54M-18.2%2022$181.64M+29.7%2021$140.08M+250.7%2020$39.95M+254.5%2019$11.27M+113.3%2018-$84.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share